Kardium has collected an FDA approval for its pulsed field ablation approach to treating atrial fibrillation, giving it the go-ahead to compete in the emerging sector against heavyweights such as ...
HAYWARD, Calif.--(BUSINESS WIRE)--Pulse Biosciences, Inc. (Nasdaq: PLSE), a company primarily focused on leveraging its novel and proprietary CellFX Nanosecond Pulsed Field Ablation (nsPFA) technology ...
LONG BEACH, Calif. -- Big Data may provide some answers to the many questions surrounding advanced catheter-based pulmonary embolism (PE) therapies, a buzzing field that otherwise has little evidence ...
FRANKLIN LAKES, N.J., Oct. 9, 2025 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced the enrollment of the first patient in ...
SAN FRANCISCO -- Noninvasive stereotactic radiotherapy (RT) for refractory ventricular tachycardia (VT) achieved outcomes similar to catheter ablation with substantially fewer serious adverse events ...
Netherlands-based medical electrospinning company Vivolta has signed a long-term partnership with UK company Neurochase to manufacture micro-catheters thatdeliver advanced therapies to the brain. The ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback